Fund Holdings — Richmond Brothers, Inc.

Total Portfolio Value:
$57.37M
Total Bought:
$952.1K
Total Sold:
$5.58M
Net Transaction:
-$4.62M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Invesco Qqq TrUNIT SER 146,63845,258-1,380$16.72M$18.53M32.31%+$1.82M
MiMedx Group, Inc.(MDXG)1,481,3321,404,352-76,980$10.80M$12.32M21.47%+$1.52M
Apple Inc.(AAPL)34,39532,730-1,665$5.89M$6.30M10.98%+$411.1K
Berkshire Hathaway Inc DelCL B15,44014,739-701$5.41M$5.26M9.16%-$152.5K
Guggenheim Strategic Opportunities FundCOM SBI(GOF)260,700297,281+36,581$3.86M$3.81M6.63%-$50.6K
Microsoft Corporation(MSFT)5,2475,205-42$1.66M$1.96M3.41%+$298.6K
Ark Etf TrINNOVATION ETF
INNOVATION ETF
38,54034,167-4,373$1.53M$1.79M3.12%+$260.0K
Ishares TrISHARES BIOTECH11,6169,285-2,331$1.42M$1.26M2.20%-$159.4K
Rockwell Medical, Inc.(RMTI)410,352412,433+2,081$853.5K$779.5K1.36%-$74.0K
Opus Genetics, Inc.(IRD)368,003252,769-115,234$1.23M$760.8K1.33%-$472.0K
Nuveen AMT-Free Municipal Credit Income Fund(NVG)57,33651,766-5,570$591.2K$611.9K1.07%+$20.7K
Amazon.com, Inc.(AMZN)3,8553,905+50$490.0K$593.3K1.03%+$103.3K
Heron Therapeutics, Inc.(HRTX)103,009296,706+193,697$106.1K$504.4K0.88%+$398.3K
Ishares TrCORE S P500 ETF9199190$394.6K$438.9K0.77%+$44.3K
Applied Therapeutics Inc123,654123,6540$307.9K$414.2K0.72%+$106.3K
McDonald's Corporation(MCD)1,2871,202-85$339.5K$356.3K0.62%+$16.8K
Air Industries Group(AIRI)111,31997,953-13,366$319.8K$318.4K0.55%-$1.5K
Durect Corp0518,294+518,294$0$305.8K0.53%+$305.8K
Axonics Inc4,7494,7490$266.5K$295.5K0.52%+$29.0K
Alphabet Inc.CL C(GOOG)1,9801,995+15$261.1K$281.2K0.49%+$20.1K
Oncternal Therapeutics Inc494,042494,0420$148.2K$264.9K0.46%+$116.7K
Verizon Communications Inc.(VZ)6,3425,767-575$205.6K$217.4K0.38%+$11.8K
Charge Enterprises Inc20,00020,0000$9.9K$2.3K0.00%-$7.7K
JOHNSON & JOHNSONCOM(JNJ)1,3490-1,349$210.3K$0—-$210.3K
PROCTER AND GAMBLE COCOM(PG)1,5490-1,549$226.0K$0—-$226.0K
Page 1 of 1
Richmond Brothers, Inc. — 13F Holdings — Q4 2023 | TickerTrail